GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) » Definitions » 3-Year Revenue Growth Rate

Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) 3-Year Revenue Growth Rate : 134.00% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Suzhou Zelgen Biopharmaceuticals Co 3-Year Revenue Growth Rate?

Suzhou Zelgen Biopharmaceuticals Co's Revenue per Share for the three months ended in Mar. 2024 was ¥0.41.

During the past 12 months, Suzhou Zelgen Biopharmaceuticals Co's average Revenue per Share Growth Rate was -3.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 134.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 8 years, the highest 3-Year average Revenue per Share Growth Rate of Suzhou Zelgen Biopharmaceuticals Co was 134.00% per year. The lowest was 134.00% per year. And the median was 134.00% per year.


Competitive Comparison of Suzhou Zelgen Biopharmaceuticals Co's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Suzhou Zelgen Biopharmaceuticals Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzhou Zelgen Biopharmaceuticals Co's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Suzhou Zelgen Biopharmaceuticals Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Suzhou Zelgen Biopharmaceuticals Co's 3-Year Revenue Growth Rate falls into.



Suzhou Zelgen Biopharmaceuticals Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Suzhou Zelgen Biopharmaceuticals Co  (SHSE:688266) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Suzhou Zelgen Biopharmaceuticals Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Suzhou Zelgen Biopharmaceuticals Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) Business Description

Traded in Other Exchanges
N/A
Address
No.209 Chenfeng Road, Yushan Town, Jiangsu Province, Kunshan, CHN
Suzhou Zelgen Biopharmaceuticals Co Ltd is engaged in research and development of new chemical and biological drugs for various therapeutic areas, including tumors, bleeding and blood diseases, and hepatobiliary diseases.
Executives
Zhang Bin Core technical personnel
Huang Gang senior management
Lv Bin Hua Directors, senior managers, core technical personn
Lu Hui Ping Directors, senior managers
Gao Qing Ping senior management
Wu Ji Sheng Directors, senior managers, core technical personn
Zhang Jun Li senior management
Wu Li Qing Core technical personnel
Core technical personnel
Sheng Ze Lin Directors, senior managers, core technical personn

Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) Headlines

No Headlines